Search research articles
Contact Us
Filters
Showing results (111-120 of 168) with videos related to
Page
of 17
Sort By:
Cancer
|
September 15, 1990
A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma
M M Zalupski, J F Ensley, J Ryan, et al.
Medical Education
|
September 1, 1978
Measuring clinical competence of medical students
F F Holmes, L H Baker, E C Torian, et al.
Cancer Research
|
August 1, 1988
Acodazole hydrochloride: phase I trial, pharmacokinetics, and evaluation of cardiotoxicity in dogs
R Pazdur, G G Chabot, C A Campbell, et al.
American Journal of Clinical Oncology
|
February 1, 1983
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung
V Ratanatharathorn, M K Samson, C D Haas, et al.
Cancer
|
March 4, 2000
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study
S K Williamson, D Lew, G J Miller, et al.
American Journal of Clinical Oncology
|
August 1, 1993
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group study
E H Kraut, T Fleming, J S Macdonald, et al.
Cancer
|
January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study
R M Bukowski, T R Fleming, J S Macdonald, et al.
Investigational New Drugs
|
February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion duration
E A Poplin, G G Chabot, R L Tuttle, et al.
Cancer
|
October 15, 1991
A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer
G T Budd, S Green, L H Baker, et al.
Cancer
|
July 1, 1973
Phase II evaluation of adriamycin in human neoplasia
R M O'Bryan, J K Luce, R W Talley, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 168) with videos related to
Sort By:
Page
of 17
Cancer
|
September 15, 1990
A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma
M M Zalupski, J F Ensley, J Ryan, et al.
Medical Education
|
September 1, 1978
Measuring clinical competence of medical students
F F Holmes, L H Baker, E C Torian, et al.
Cancer Research
|
August 1, 1988
Acodazole hydrochloride: phase I trial, pharmacokinetics, and evaluation of cardiotoxicity in dogs
R Pazdur, G G Chabot, C A Campbell, et al.
American Journal of Clinical Oncology
|
February 1, 1983
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung
V Ratanatharathorn, M K Samson, C D Haas, et al.
Cancer
|
March 4, 2000
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study
S K Williamson, D Lew, G J Miller, et al.
American Journal of Clinical Oncology
|
August 1, 1993
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group study
E H Kraut, T Fleming, J S Macdonald, et al.
Cancer
|
January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study
R M Bukowski, T R Fleming, J S Macdonald, et al.
Investigational New Drugs
|
February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion duration
E A Poplin, G G Chabot, R L Tuttle, et al.
Cancer
|
October 15, 1991
A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer
G T Budd, S Green, L H Baker, et al.
Cancer
|
July 1, 1973
Phase II evaluation of adriamycin in human neoplasia
R M O'Bryan, J K Luce, R W Talley, et al.
Page
of 17